Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants

Lalitha Venkataraman, Ping He, Philip Schulz, Michael R. Sierks

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Reagents that can selectively recognize specific toxic tau variants associated with onset and progression of Alzheimer's disease (AD) and other tauopathies can be effective diagnostic and therapeutic tools. We utilized a novel atomic force microscopy–based biopanning protocol to isolate antibody fragments (single chain variable fragments, scFvs) that selectively bind tau variants present in human AD but not cognitively normal age-matched brain tissue. We identified 6 scFvs [Alzheimer's disease tau (ADT)-1 through 6] that readily distinguished between AD and control tissue and sera samples. We utilized 3 of the scFvs (ADT-2, ADT-4, and ADT-6) to analyze longitudinal plasma samples from 50 human patients, 25 patients which converted to AD during the study and 25 that remained cognitively normal. All 3 scFvs could distinguish the AD from control samples with higher tau levels in apolipoprotein E3/3 AD cases compared to apolipoprotein E3/4. Immunohistochemical analyses of human AD brain slices indicated several but not all tau variants overlapping with phosphorylated tau staining. Several reagents also showed therapeutic potential, protecting neuronal cells against AD tau-induced toxicity.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalNeurobiology of Aging
Volume94
DOIs
StatePublished - Oct 2020

Keywords

  • Alzheimer's disease
  • Biomarker
  • Single chain antibody fragment
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants'. Together they form a unique fingerprint.

  • Cite this